🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities.

P W Pisters, D H Leung et al. (1996)

Journal of Clinical Oncology

1.0K citesjournal articlePDF

[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

Michael S Hofman, John Violet et al. (2018)

The Lancet Oncology

1.0K citesjournal articlePDF

Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update

Muneeb Ahmed, Luigi Solbiati et al. (2014)

Radiology

1.0K citesjournal articlePDF

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer

Kohei Shitara, Eric Van Cutsem et al. (2020)

JAMA Oncology

1.0K citesjournal articlePDF

Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma Patients

Jeffrey E. Gershenwald, William Thompson et al. (1999)

Journal of Clinical Oncology

1.0K citesjournal articlePDF

Randomized controlled trial of screening for hepatocellular carcinoma

Bo-Heng Zhang, Bing-Hui Yang et al. (2004)

Journal of Cancer Research and Clinical Oncology

1.0K citesjournal articlePDF

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

J Baselga, D Tripathy et al. (1996)

Journal of Clinical Oncology

1.0K citesjournal articlePDF

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

Viviana Galimberti, Bernard F Cole et al. (2013)

The Lancet Oncology

1.0K citesjournal articlePDF

Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

M. Pavel, K. Öberg et al. (2020)

Annals of Oncology

1.0K citesjournal articlePDF

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Martin J. van den Bent, Alba A. Brandes et al. (2013)

Journal of Clinical Oncology

1.0K citesjournal articlePDF

Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure

James S. Tomlinson, William R. Jarnagin et al. (2007)

Journal of Clinical Oncology

1.0K citesjournal articlePDF

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

Ken Kato, Byoung Chul Cho et al. (2019)

The Lancet Oncology

1.0K citesjournal articlePDF

Unlocking the potential of antibody–drug conjugates for cancer therapy

Joshua Z. Drago, Shanu Modi et al. (2021)

Nature Reviews Clinical Oncology

1.0K citesjournal articlePDF

Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer

John Mendelsohn, Jose Baselga (2003)

Journal of Clinical Oncology

1.0K citesjournal articlePDF

Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy

Jarushka Naidoo, Xuan Wang et al. (2017)

Journal of Clinical Oncology

1.0K citesjournal articlePDF